Metaplastic breast cancer (MpBC) is an exceedingly rare breast cancer variant that is
therapeutically challenging and aggressive. MpBC is defined by the histological presence of …

Obese postmenopausal women have an increased breast cancer risk, the principal
mechanism for which is elevated estrogen production by adipose tissue; also, regardless of …

Cancers harbor significant genetic heterogeneity and patterns of relapse following many
therapies are due to evolved resistance to treatment. While efforts have been made to …

Background Breast cancer (BC) remains the most commonly diagnosed malignancy in
women. We investigated 4 straight aldehydes in the exhaled breath as potential early BC …

Many experimental models demonstrated that inorganic and organic selenium (Se)
compounds may have an anticancer activity. However, large clinical studies failed to …

It has been reported that dense intratumoral infiltration of Foxp3+ Tregs (Tregs) was an
independent factor for poor prognosis of breast cancer (BC) patients. However, the cytokines …

Notwithstanding the advances in tumor research, diagnosis, and treatment, breast cancer is
still a challenge worldwide. This global burden of disease has been associated with …

Triple-negative breast cancer (TNBC) is one of the most aggressive subtypes of breast
cancer, marked by poor outcomes and dismal prognosis. Due to the absence of targetable …

Triple negative breast cancers (TNBCs), which are defined as estrogen-receptor,
progesterone-receptor, and HER2-receptor negative, account for 10–20% of breast cancers …

Summary Rhenium (I)-diselenother (Re-diselenoether) is a water soluble metal-based
compound, combining one atom of rhenium and two atoms of selenium. This compound has …